LINFOMAS Y TRASPLANTES
Azienda Ospedaliero-Universitaria Careggi
Florencia, ItaliaPublications en collaboration avec des chercheurs de Azienda Ospedaliero-Universitaria Careggi (7)
2024
-
Improved outcome of COVID-19 over time in patients treated with CAR T-cell therapy: Update of the European COVID-19 multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party (IDWP) and the European Hematology Association (EHA) Lymphoma Group
Leukemia, Vol. 38, Núm. 9, pp. 1985-1991
2023
2017
-
Long-term survival of patients with CLL after allogeneic transplantation: A report from the European Society for Blood and Marrow Transplantation
Bone Marrow Transplantation, Vol. 52, Núm. 3, pp. 372-380
2012
-
High-Dose Therapy and Autologous Stem Cell Transplantation in First Relapse for Diffuse Large B Cell Lymphoma in the Rituximab Era: An Analysis Based on Data from the European Blood and Marrow Transplantation Registry
Biology of Blood and Marrow Transplantation, Vol. 18, Núm. 5, pp. 788-793
2009
-
Reduced intensity conditioning allogeneic stem cell transplantation for Hodgkin's lymphoma: Identification of prognostic factors predicting outcome
Haematologica, Vol. 94, Núm. 2, pp. 230-238
2003
2002
-
Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia
Blood, Vol. 100, Núm. 12, pp. 3877-3886